Back to Search
Start Over
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D study
- Source :
- Journal of the International AIDS Society, 21(3):e25083. International AIDS Society, Journal of the International AIDS Society, Journal of the International AIDS Society, 21, 3, pp. e25083, Journal of the International AIDS Society, 21(3):25083. John Wiley & Sons Inc., Østergaard, L J & Data Collection of Adverse Events of Anti-HIV drugs (D:A:D) Study group 2018, ' Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study ', International AIDS Society. Journal, vol. 21, no. 3 . https://doi.org/10.1002/jia2.25083, Journal of the International AIDS Society, 21 (3, JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, Journal of the International AIDS Society, 21, e25083
- Publication Year :
- 2018
-
Abstract
- There is paucity of data related to potential gender differences in the use of interventions to prevent and treat cardiovascular disease (CVD) among HIV-positive individuals. We investigated whether such differences exist in the observational D:A:D cohort study. Methods: Participants were followed from study enrolment until the earliest of death, six months after last visit or February 1, 2015. Initiation of CVD interventions [lipid-lowering drugs (LLDs), angiotensin-converting enzyme inhibitors (ACEIs), anti-hypertensives, invasive cardiovascular procedures (ICPs) were investigated and Poisson regression models calculated whether rates were lower among women than men, adjusting for potential confounders. Results: Women (n = 12,955) were generally at lower CVD risk than men (n = 36,094). Overall, initiation rates of CVD interventions were lower in women than men; LLDs: incidence rate 1.28 [1.21, 1.35] vs. 2.40 [2.34, 2.46]; ACEIs: 0.88 [0.82, 0.93] vs. 1.43 [1.39, 1.48]; anti-hypertensives: 1.40 [1.33, 1.47] vs. 1.72 [1.68, 1.77] and ICPs: 0.08 [0.06, 0.10] vs. 0.30 [0.28, 0.32], and this was also true for most CVD interventions when exclusively considering periods of follow-up for which individuals were at high CVD risk. In fully adjusted models, women were less likely to receive CVD interventions than men (LLDs: relative rate 0.83 [0.78, 0.88]; ACEIs: 0.93 [0.86, 1.01]; ICPs: 0.54 [0.43, 0.68]), except for the receipt of anti-hypertensives (1.17 [1.10, 1.25]). Conclusion: The use of most CVD interventions was lower among women than men. Interventions are needed to ensure that all HIV-positive persons, particularly women, are appropriately monitored for CVD and, if required, receive appropriate CVD interventions.<br />SCOPUS: ar.j<br />info:eu-repo/semantics/published
- Subjects :
- Male
Cardiovascular disease
gender
cardiovascular disease interventions
cohort studies
HIV
women
myocardial infarction
stroke
Heart disease
Psychological intervention
lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4]
030204 cardiovascular system & hematology
Santé publique
ACUTE CORONARY SYNDROME
10234 Clinic for Infectious Diseases
Cohort Studies
0302 clinical medicine
Risk Factors
HIV Seropositivity
Medicine and Health Sciences
IN-HOSPITAL MORTALITY
030212 general & internal medicine
Pathologie maladies infectieuses
Stroke
Research Articles
PRESENTATION
GENERAL-POPULATION
INFECTED PATIENTS
Sex Characteristics
Confounding
Middle Aged
3. Good health
Infectious Diseases
Cardiovascular Diseases
Cardiovascular disease interventions
Cohort studies
Gender
Hiv
Myocardial infarction
Women
symbols
Female
Cohort study
Research Article
Adult
medicine.medical_specialty
Acute coronary syndrome
ACUTE MYOCARDIAL-INFARCTION
SEX-DIFFERENCES
SYMPTOM PRESENTATION
education
610 Medicine & health
HEART-DISEASE
NO
INFECTED
03 medical and health sciences
symbols.namesake
Internal medicine
cardiovascular disease intervention
PATIENTS
medicine
Humans
SYMPTOM
Poisson regression
IN-HOSPITAL
business.industry
MORTALITY
CLINICAL PRESENTATION
Public Health, Environmental and Occupational Health
2739 Public Health, Environmental and Occupational Health
2725 Infectious Diseases
medicine.disease
lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]
10036 Medical Clinic
3121 General medicine, internal medicine and other clinical medicine
RISK-FACTORS
Observational study
business
cohort studie
Subjects
Details
- Language :
- English
- ISSN :
- 17582652
- Database :
- OpenAIRE
- Journal :
- Journal of the International AIDS Society, 21(3):e25083. International AIDS Society, Journal of the International AIDS Society, Journal of the International AIDS Society, 21, 3, pp. e25083, Journal of the International AIDS Society, 21(3):25083. John Wiley & Sons Inc., Østergaard, L J & Data Collection of Adverse Events of Anti-HIV drugs (D:A:D) Study group 2018, ' Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study ', International AIDS Society. Journal, vol. 21, no. 3 . https://doi.org/10.1002/jia2.25083, Journal of the International AIDS Society, 21 (3, JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, Journal of the International AIDS Society, 21, e25083
- Accession number :
- edsair.doi.dedup.....47fc4d8ba63bce21acc6164caef5655a